The potent immunosuppressants ascomycin, FK506 and rapamycin are polyketide secondary metabolites that are biosynthesized from an usual shikimate-derived (1 7?,3i?,4i?)-3,4 ,-dihydroxycyclohexanecarboxylic acid (DHCHC) starter unit1"4*. The biosynthetic pathway to this DHCHC moiety of ascomycin has been investigated in Streptomyces hygroscopicus var. ascornyceticus by a series of incorporation experiments with isotopically labeled shikimic acid and various putative pathway intermediates1}.
The results obtained were consistent with a process that initiates with either a syn or an anti 1,4-conjugate elimination of a C6 hydrogen and the C3 hydroxyl group of shikimic acid to produce (37?,47?)-3,4-dihydroxyl ,5-cyclohexadienecarboxylic acid (1) (Fig. 1 ). Asyn reduction of the A x-double bond of 1 gives of (lS,4/?,57?)-4,5-dihydroxycyclohex-2-enecarboxylic acid (2), which is subsequently converted to (4/?,5/?)-4,5-dihydroxycyclohexl-enecarboxylic acid (3) by an isomerization of the remaining double bond from the A2 to the Ax position. In the final step of the process 3 is converted,to DHCHC by an anti addition of hydrogen to the re faces ofCl and C2. An alternative pathway in which the first double bond is reduced by an anti addition of hydrogen (1->2), while consistent with the experimental results, seems unlikely as it would require a subsequent unprecedented antarafacial rearrangement to generate 31}.
The only stereochemical detail of DHCHC biosynthesis that remains undetermined is the steric course of the initial 1,4-conjugate elimination.
Previous incorporation studies with (-)-6(i?,S)- had generated ascomycin which exhibited a single 2H (Fig. 1)5) . The CHC and DHCHCpathways apparently diverge after this first step. Analysis of the rapamycin polyketide synthase provides strong evidence that this enzyme utilizes DHCHC as a free acid suggesting that the syn reduction of the A^double bond of 1 in this pathway occurs with the free acid3'6). Evidence indicates that in the CHC pathway 1 is first converted to a coenzyme A thioester and that the A^double bond of this compound is then reduced in an anti fashion ( Fig.  1) 7~9. It has been proposed that these stereochemical differences reflect differing progenitors for the enoyl reductases in these two pathways10*. By the same token the dehydratases responsible for converting shikimate to 1 in the same stereochemical fashion in these two pathways may be related. It has previously been noted that chorismate synthase also catalyzes an anti 1 ,4-elimination reaction using 5-enolpyruvylshikimate 3-phosphate in a later step in the shikimate pathway5).
The evolutionary relationship of all of these dehydratases, however, will only be determined once the corresponding genes have been cloned. Someprogress has been madein this direction; an enoyl CoAreductase involved in the CHCpathway has already been cloned and sequenced7), and analysis of the surrounding genes has provided evidence ofa CHCbiosynthetic gene cluster (unpublished data).
